$56.60
1.192.15%
al cierre: -
$56.85
0.250.44%
After hour: 5:38 PM EDT
Comments
Loading...
Informe de interés en corto
El interés corto en CRISPR Therapeutics AG (NASDAQ:CRSP) ha disminuido durante el último período de informe, aumentando en descenso desde 25.30M hasta 23.45M. Esto representa el 29.11% de las acciones disponibles públicamente de la empresa.
El interés en corto en CRISPR Therapeutics Corp (XNAS:CRSP) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 4.06M acciones negociadas por día, tomaría 5.78 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
23.45M
Interés en corto %
29.1%
Días para cubrir
5.78
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG Common | 07/31/2025 | 08/11/2025 | 29.11% | 80,541,115 | 23,446,400 | 4,056,955 | 5.78 | |
CRSP | CRISPR Therapeutics AG Common | 07/15/2025 | 07/24/2025 | 33.30% | 75,954,376 | 25,295,875 | 3,279,650 | 7.71 | |
CRSP | CRISPR Therapeutics AG Common | 06/30/2025 | 07/10/2025 | 33.63% | 75,954,376 | 25,542,468 | 4,384,022 | 5.83 | |
CRSP | CRISPR Therapeutics AG Common | 06/13/2025 | 06/25/2025 | 28.19% | 75,954,376 | 21,409,921 | 2,524,184 | 8.48 | |
CRSP | CRISPR Therapeutics AG Common | 05/30/2025 | 06/10/2025 | 27.04% | 75,954,376 | 20,539,111 | 1,933,171 | 10.62 | |
CRSP | CRISPR Therapeutics AG Common | 05/15/2025 | 05/27/2025 | 27.73% | 75,954,376 | 21,065,431 | 2,131,226 | 9.88 | |
CRSP | CRISPR Therapeutics AG Common | 04/30/2025 | 05/09/2025 | 28.07% | 75,954,376 | 21,319,453 | 1,570,304 | 13.58 | |
CRSP | CRISPR Therapeutics AG Common | 04/15/2025 | 04/25/2025 | 27.34% | 75,953,854 | 20,764,751 | 2,871,127 | 7.23 | |
CRSP | CRISPR Therapeutics AG Common | 03/31/2025 | 04/09/2025 | 27.08% | 75,728,599 | 20,510,014 | 1,760,536 | 11.65 | |
CRSP | CRISPR Therapeutics AG Common | 03/14/2025 | 03/25/2025 | 26.82% | 75,728,599 | 20,307,836 | 1,691,868 | 12 | |
CRSP | CRISPR Therapeutics AG Common | 02/28/2025 | 03/11/2025 | 27.48% | 75,728,599 | 20,808,121 | 2,762,173 | 7.53 | |
CRSP | CRISPR Therapeutics AG Common | 02/14/2025 | 02/26/2025 | 26.95% | 75,728,599 | 20,407,467 | 2,657,292 | 7.68 | |
CRSP | CRISPR Therapeutics AG Common | 01/31/2025 | 02/11/2025 | 25.88% | 75,307,604 | 19,491,883 | 2,080,983 | 9.37 | |
CRSP | CRISPR Therapeutics AG Common | 01/15/2025 | 01/27/2025 | 26.97% | 75,307,604 | 20,311,420 | 1,803,942 | 11.26 | |
CRSP | CRISPR Therapeutics AG Common | 12/31/2024 | 01/10/2025 | 25.36% | 75,307,604 | 19,097,155 | 1,799,431 | 10.61 | |
CRSP | CRISPR Therapeutics AG Common | 12/13/2024 | 12/24/2024 | 24.06% | 75,307,604 | 18,116,755 | 2,033,615 | 8.91 | |
CRSP | CRISPR Therapeutics AG Common | 11/29/2024 | 12/10/2024 | 24.11% | 75,307,604 | 18,153,184 | 1,573,441 | 11.54 | |
CRSP | CRISPR Therapeutics AG Common | 11/15/2024 | 11/26/2024 | 25.75% | 75,307,604 | 19,390,540 | 2,161,975 | 8.97 | |
CRSP | CRISPR Therapeutics AG Common | 10/31/2024 | 11/11/2024 | 24.68% | 75,307,604 | 18,587,119 | 1,152,226 | 16.13 | |
CRSP | CRISPR Therapeutics AG Common | 10/15/2024 | 10/24/2024 | 23.42% | 75,122,283 | 17,592,960 | 956,558 | 18.39 | |
CRSP | CRISPR Therapeutics AG Common | 09/30/2024 | 10/09/2024 | 23.38% | 75,122,283 | 17,560,892 | 1,149,590 | 15.28 | |
CRSP | CRISPR Therapeutics AG Common | 09/13/2024 | 09/24/2024 | 23.35% | 75,122,283 | 17,543,484 | 912,940 | 19.22 | |
CRSP | CRISPR Therapeutics AG Common | 08/30/2024 | 09/11/2024 | 23.21% | 75,122,283 | 17,439,381 | 873,074 | 19.97 | |
CRSP | CRISPR Therapeutics AG Common | 08/15/2024 | 08/26/2024 | 22.86% | 75,122,283 | 17,174,029 | 1,529,441 | 11.23 | |
CRSP | CRISPR Therapeutics AG Common | 07/31/2024 | 08/09/2024 | 21.87% | 75,122,283 | 16,428,259 | 1,345,272 | 12.21 | |
CRSP | CRISPR Therapeutics AG Common | 07/15/2024 | 07/24/2024 | 21.52% | 74,872,218 | 16,115,832 | 1,126,602 | 14.3 | |
CRSP | CRISPR Therapeutics AG Common | 06/28/2024 | 07/10/2024 | 20.91% | 74,872,218 | 15,652,762 | 1,431,314 | 10.94 | |
CRSP | CRISPR Therapeutics AG Common | 06/14/2024 | 06/26/2024 | 19.86% | 74,872,218 | 14,866,549 | 1,448,128 | 10.27 | |
CRSP | CRISPR Therapeutics AG Common | 05/31/2024 | 06/11/2024 | 20.92% | 74,872,218 | 15,660,985 | 1,014,070 | 15.44 | |
CRSP | CRISPR Therapeutics AG Common | 05/15/2024 | 05/24/2024 | 20.48% | 74,872,218 | 15,334,922 | 1,552,550 | 9.88 | |
CRSP | CRISPR Therapeutics AG Common | 04/30/2024 | 05/09/2024 | 19.48% | 74,872,218 | 14,586,850 | 1,299,948 | 11.22 | |
CRSP | CRISPR Therapeutics AG Common | 04/15/2024 | 04/24/2024 | 19.70% | 74,837,216 | 14,744,982 | 1,275,409 | 11.56 | |
CRSP | CRISPR Therapeutics AG Common | 03/28/2024 | 04/09/2024 | 19.72% | 74,837,216 | 14,757,233 | 1,210,457 | 12.19 | |
CRSP | CRISPR Therapeutics AG Common | 03/15/2024 | 03/26/2024 | 18.59% | 79,226,030 | 14,724,239 | 1,446,048 | 10.18 | |
CRSP | CRISPR Therapeutics AG Common | 02/29/2024 | 03/11/2024 | 19.01% | 79,226,030 | 15,061,974 | 2,562,232 | 5.88 | |
CRSP | CRISPR Therapeutics AG Common | 02/15/2024 | 02/27/2024 | 18.77% | 79,226,030 | 14,874,679 | 2,491,670 | 5.97 | |
CRSP | CRISPR Therapeutics AG Common | 01/31/2024 | 02/09/2024 | 20.08% | 78,382,526 | 15,740,331 | 1,770,074 | 8.89 | |
CRSP | CRISPR Therapeutics AG Common | 01/12/2024 | 01/24/2024 | 21.74% | 78,382,526 | 17,038,104 | 2,262,624 | 7.53 | |
CRSP | CRISPR Therapeutics AG Common | 12/29/2023 | 01/10/2024 | 20.73% | 78,382,526 | 16,250,367 | 2,390,400 | 6.8 | |
CRSP | CRISPR Therapeutics AG Common | 12/15/2023 | 12/27/2023 | 22.10% | 78,382,526 | 17,325,024 | 4,803,895 | 3.61 | |
CRSP | CRISPR Therapeutics AG Common | 11/30/2023 | 12/11/2023 | 20.32% | 78,382,526 | 15,927,411 | 3,479,501 | 4.58 | |
CRSP | CRISPR Therapeutics AG Common | 11/15/2023 | 11/27/2023 | 20.89% | 78,382,526 | 16,370,356 | 2,876,641 | 5.69 | |
CRSP | CRISPR Therapeutics AG Common | 10/31/2023 | 11/09/2023 | 17.72% | 78,382,526 | 13,889,941 | 1,527,256 | 9.09 | |
CRSP | CRISPR Therapeutics AG Common | 10/13/2023 | 10/24/2023 | 17.30% | 78,361,530 | 13,553,295 | 1,152,134 | 11.76 | |
CRSP | CRISPR Therapeutics AG Common | 09/29/2023 | 10/10/2023 | 16.64% | 78,361,530 | 13,042,772 | 844,067 | 15.45 | |
CRSP | CRISPR Therapeutics AG Common | 09/15/2023 | 09/26/2023 | 17.60% | 78,361,530 | 13,788,718 | 795,876 | 17.33 | |
CRSP | CRISPR Therapeutics AG Common | 08/31/2023 | 09/12/2023 | 17.97% | 78,361,530 | 14,084,106 | 886,619 | 15.89 | |
CRSP | CRISPR Therapeutics AG Common | 08/15/2023 | 08/24/2023 | 17.11% | 78,361,530 | 13,408,304 | 1,226,323 | 10.93 |
En busca de los valores más cortos?